Card image cap

Raja Krishnamoorthi's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic for U.S. House (IL) - District 8

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 2
Date Title
09/26/2023 Durbin, Wyden, Krishnamoorthi, Colleagues Introduce Bicameral Bill To Reduce Tobacco Use In America
04/28/2022 Congressman Krishnamoorthi Welcomes FDA Decision To Ban Menthol Cigarettes And Flavored Cigars, Calls On Agency To Also Ban Flavored E-Cigarettes
03/09/2022 Congressman Krishnamoorthi To Big Vape: Your Days Of Exploiting The Synthetic Nicotine Loophole Are Over
12/15/2021 Congressman Krishnamoorthi Introduces Bipartisan Legislation To Prevent Big Tobacco And Vaping Companies From Preying On Children With Synthetic Nicotine Loophole
11/26/2021 Congressman Krishnamoorthi Urges Senate To Pass Build Back Better Act With Provisions He Championed To Address Green Card Backlog
11/19/2021 Congressman Krishnamoorthi Votes In Favor Of Transformational Build Back Better Act
05/13/2021 Trone, Krishnamoorthi, Stewart Introduce Bipartisan Legislation to Curb Youth Vaping
05/07/2021 Congressman Raja Krishnamoorthi Reintroduces The END ENDS Act To Limit Nicotine Concentration In E-Cigarettes And Mitigate Youth Addiction
12/23/2020 Congressman Krishnamoorthi Condemns CEO Of Purdue Pharma L.P. Still Receiving $3 Million Bonus After The Company Pleaded Guilty To Three Felony Counts
12/22/2020 Warren, Blumenthal, Durbin, Krishnamoorthi And DeGette Question Tobacco Companies Exploitative E-Cigarette Advertisements During The COVID-19 Pandemic
01/23/2020 Letter to Alex Azar, Secretary of the Department of Health and Human Services - Lawmakers Call on Administration to Ban Flavored Vaping Products
01/01/2020 Issue Position: Reducing Opioid Abuse
10/11/2019 DuPage County Health Department Secures Nearly $1.2 Million Grant To Provide Opioid Treatment Options For Incarcerated People
09/05/2019 Letter to the Hon. Doctor Ned Sharpless, Acting Commissioner of the Food and Drug Administration - Subcommittee Chairman Krishnamoorthi Urges FDA To Evaluate JUUL Labs' False Medical Claims About E-Cigarettes
08/23/2019 Illinois Congressman Raja Krishnamoorthi Responds To Vaping-Linked Death Of Illinois Man, The First In The Nation
09/27/2018 Congressman Krishnamoorthi Commends Additional Funding To Fight Opioid Abuse Included In Appropriations Legislation
09/24/2018 Congressman Krishnamoorthi Applauds Increased Funding To Combat Opioid Abuse Among Veterans
05/24/2018 US House Passes Rep. Krishnamoorthi's Amendment Requiring Department of Defense to Report on Plans to Treat and Prevent Opioid Use Among Families of Servicemembers
04/12/2018 Congressmen Raja Krishnamoorthi Leads Oversight Committee Hearing On Local Efforts To Combat The Opioid Epidemic And How Congress Can Better Support Them
10/19/2017 Letter to Robert W. Patterson, DEA - Answers about DEA's Relationship with Pharma
05/16/2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding
04/03/2017 The Chicago Tribune - With Trumpcare Off The Table, Let's Address The High Cost Of Prescription Drugs
03/29/2017 Letter to the Hon. Chariman John Culberson, Hon. Chairman Tom Cole, Hon. Chairman Tom Graves, Hon. Ranking Member Jose Serrano, Hon. Ranking Member Rosa DeLauro, Hon. Ranking Member Mike Quigley of the House Committee on Appropriations - Bipartisan Heroin Task Force Calls for Funding of the Comprehensive Addiction and Recovery Act
03/22/2017 Hearing of the Health Care, Benefits and Administrative Rules Subcommittee of the House Oversight and Government Reform Committee - Opening Statement of Rep. Krishnamoorthi, Hearing on Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain
02/21/2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike
Page 1 of 2
arrow_upward